This study aims to investigate the microbial effect in pancreatic cancer (PC) progression (e.g., metastasis or recurrence) during adjuvant chemotherapy after surgical resection. It also explores the occurrence of antibiotic resistance in fecal samples from patients with PC. Here, we used a metagenomics approach to profile the microbial community, antibiotic resistance genes (ARGs), and mobile genetic elements (MGEs) related to the mobilization of ARGs in fecal samples from patients with PC with and without metastatic cancer and their spouses or family members (as control). </p
BACKGROUND: We investigated whether chemotherapy with the presence or absence of antibiotics against...
BackgroundBody weight (BW) loss is prevalent in patients with pancreatic cancer (PC). Gut microbiota...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers and is projected to be the...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
Pancreatic cancer (PC) is an aggressive disease with a high mortality and poor prognosis. The human ...
Association studies have linked microbiome alterations with many human diseases. However, they have ...
Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth-most diagnosed cancer in the world. ...
Treatment options for metastatic pancreatic ductal adenocarcinoma (mPDAC) patients remain limited, m...
The composition of resident microbes in the human body is linked to various diseases and their treat...
BACKGROUND: We investigated whether chemotherapy with the presence or absence of antibiotics against...
BackgroundBody weight (BW) loss is prevalent in patients with pancreatic cancer (PC). Gut microbiota...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers and is projected to be the...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
BackgroundPancreatic cancer is one of the deadliest cancer, with a 5-year overall survival rate of 1...
Pancreatic cancer (PC) is an aggressive disease with a high mortality and poor prognosis. The human ...
Association studies have linked microbiome alterations with many human diseases. However, they have ...
Pancreatic ductal adenocarcinoma (PDAC) is currently the fourth-most diagnosed cancer in the world. ...
Treatment options for metastatic pancreatic ductal adenocarcinoma (mPDAC) patients remain limited, m...
The composition of resident microbes in the human body is linked to various diseases and their treat...
BACKGROUND: We investigated whether chemotherapy with the presence or absence of antibiotics against...
BackgroundBody weight (BW) loss is prevalent in patients with pancreatic cancer (PC). Gut microbiota...
Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal cancers and is projected to be the...